期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

超滤在心力衰竭治疗中的价值和展望 被引量：5

The Future and Current Role of Ultrafiltration in Patients with Heart Failure
下载PDF
导出
摘要 容量负荷过重是心力衰竭患者反复住院的主要原因,钠潴留是核心的病理生理环节。血液超滤是治疗液体潴留的"金标准"。现有证据表明超滤能改善心力衰竭转归,降低再住院率。现综述超滤治疗心力衰竭的机制、有效性、安全性、适应证以及未来的研究方向。 The high readmission rate of heart failure is due mainly to fluid overload and sodium retention plays a pivotal role in the pathophysiologie process. Ultrafiltration is the gold standard for sodium-volume removal. The available evidence supports that uhrafihration improve outcomes in patients with acute deeompensated heart failure. This review illustrates technical issues, mechanisms, efficacy, safety, indications and directions of ultrafiltration in heart failure.
作者 冯新庆
机构地区 中国中医科学院西苑医院CCU
出处 《心血管病学进展》 CAS 2014年第1期5-8,共4页 Advances in Cardiovascular Diseases
关键词 超滤 心力衰竭 钠水潴留 ultrafiltration heart failure sodium and water retention
分类号 R541.6 [医药卫生—心血管疾病]
  • 相关文献

参考文献18

  • 1Adams KF,Fonamw GC,Emerman CL. Characteristics and outcomes of patients hospitalized for heart failure in the United States:rational,design,and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)[J].{H}American Heart Journal,2005.209-216.
  • 2Cleland JG,Swedberg K,Kollath F. The Euro-Heart Failure Survey programme-a survey on the quality of care among patients with heart failure in Europe.Part 1:patient characteristics and diagnosis[J].{H}EUROPEAN HEART JOURNAL,2003.442-463.
  • 3Fonarow GC,Abraham WT,Albert NM. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZEHF):rational and design[J].{H}American Heart Journal,2004.43-51.
  • 4Schrier RW. Role of diminished renal function in cardiovascular mortality:marker or pathogenetic factor[J].{H}Journal of the America College of Cardiology,2006.1-8.
  • 5Gheorghiade M,Zannad F,Sopko G. Acute heart failure syndromes:current state and framework for future research[J].{H}CIRCULATION,2005.3958-3968.
  • 6Davis KL,Laine GA,Geissler HJ. Effects of myocardial edema on the development of myocardial interstitial fibrosis[J].{H}MICROCIRCULATION,2000.269-280.
  • 7Mullens W,Abrahams Z,Francis GS. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure[J].{H}Journal of the America College of Cardiology,2009.589-596.
  • 8Bayliss J,Norell M,Canepa-Anson R. Untreated heart failure:clinical and neuroendocrine effects of introducing diuretics[J].{H}British Heart Journal,1987.17-22.
  • 9Francis GS,Siegel RM,Goldsmith SR. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure.Activation of the neurohumoral axis[J].{H}ANNALS OF INTERNAL MEDICINE,1985.1-6.
  • 10Gotdieb SS,Brater DC,Thomas I. BG9719,an A1 adenosine receptor antagonist,protects against the decline in renal function observed with diuretic therapy[J].{H}CIRCULATION,2002.1743.

同被引文献38

  • 1卫生部心血管病防治研究中心.中国心血管病报告2013[M].北京:中国大百科全书出版社,2014.
  • 2Mozaffarlan D, Benjamin E J, Go AS, et al. Heart disease and stroke statistics-2015 update: A report from the American Heart Association [ J ]. Circulation, 2015,131 : e2 - e294.
  • 3Braunwald E. The war against heart failure: the Lancet lecture [ J]. Lancet, 2015,385(9970) :812 -824.
  • 4Krum H. Heart failure: 10 Years of progress in HF research - what have we learned? [ J]. Nat Rev Cardiol, 2014, 11 (11) :631 -633.
  • 5Stamm C, Kleine HD, Choi YH, et al. Intramyocardial delivery of CD133 + bone marrow ceils and coronary artery bypass grafting for chronic isehemic heart disease: safety and efficacy studies[J]. J Tho- rae Cardiovasc Surg, 2007, 133 : 717 - 725.
  • 6Hare JM, Traverse JH, Henry TD, et al. A randomized, double - blind, placebo - controlled, dose - escalation study of intravenous a- dult human mesenehymal stem cells (proehymal) after acute myocar- dial infarction[ J]. J Am Coll Cardiel, 2009, 54:2277 -2286.
  • 7Tang WHW, Wang Z, Fan Y, et al. Prognostic value of elevated lev- els of intestinal microbe - generated metabolite trimethylamine - N - oxide in patients with heart failure: refining the gut hypothesls[ J ]. J Am Coll Cardiol,2014 ,64 :1908 - 1914.
  • 8陈可冀,董泉珍.传统医药治疗心力衰竭的研究评述[J].天津中医,1985,2(5):31-36.
  • 9Li X, Zhang J, Huang J, et al. A multicenter, randomized, double- blind, parallel - group, placebo - controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure [ J]. J Am Coll Cardiol, 2013,62(12) :1065 - 1072.
  • 10Guo N, Yang D, Wang X, et al. Metabonomic study of chronic heart failure and effects of Chinese herbal decoction in rats [ J]. J Chroma- tour A. 2014. 1362:89 - 10l.

引证文献5

二级引证文献33

心血管病学进展
2014年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部